Statement from Shatterproof on DEA's Temporary Scheduling of 7-Hydroxymitragynine (7-OH) and Related Substances
Shatterproof frames DEA's decision as a crucial step in addressing the opioid crisis, emphasizing its positive impact.
View original on prnewswire.comOverview
Shatterproof applauds DEA's temporary scheduling of 7-Hydroxymitragynine and related substances, a crucial step in addressing opioid crisis.
TL;DR
- Shatterproof praises DEA decision
- Temporary scheduling aims to curb opioid proliferation
Key Stats
Questions Answered
Keywords
Narrative Frame
The Halo
Spin Score
90%
Framing minimizes potential risks and complexities of temporary scheduling.
Who Benefits If This Frame Spreads
The Frame
Altruistic reframing — Shatterproof positions itself as a champion for public good.
Missing Context
- Potential negative consequences of temporary scheduling
SpinGraph
How this belief gets built
Claim → Frame → Beneficiary → Gap → AI Risk
Shatterproof frames DEA's decision as a crucial step in addressing the opioid crisis, emphasizing its positive impact.
- Claim
Temporary scheduling of 7-Hydroxymitragynine and related substances is a crucial
Temporary scheduling of 7-Hydroxymitragynine and related substances is a crucial step in addressing the opioid crisis.
- Frame
Progress framed as virtuous
Altruistic reframing — Shatterproof positions itself as a champion for public good.
- Beneficiary
Shatterproof
- Gap
Potential negative consequences of temporary scheduling
- AI Risk
AI may repeat: “Shatterproof praises DEA's decision to temporarily schedule 7-Hydroxymitragynine”
Shatterproof praises DEA's decision to temporarily schedule 7-Hydroxymitragynine.
Claim Ledger
| Claim | Evidence | Verification | Risk | Evidence Gaps |
|---|---|---|---|---|
| Temporary scheduling of 7-Hydroxymitragynine and related substances is a crucial step in addressing the opioid crisis. | Article cites DEA's decision but lacks detailed analysis of its impact. | Partially Verified In Source | Moderate | Third-party proof not present |
Temporary scheduling of 7-Hydroxymitragynine and related substances is a crucial step in addressing the opioid crisis.
evidence: Article cites DEA's decision but lacks detailed analysis of its impact.
"Shatterproof applauds the U.S. Drug Enforcement Administration's decision to temporarily schedule 7-hydroxymitragynine (7-OH) and related substances."
Evidence Gaps
- Third-party proof not present
Fact Check Signals
0 of 1 claim matched · confidence: low · checked July 8, 2026
Temporary scheduling of 7-Hydroxymitragynine and related substances is a crucial step in addressing the opioid crisis.
Language Heatmap
Loaded terms that carry the frame beyond the facts.
Statement from Shatterproof on DEA's Temporary Scheduling of 7-Hydroxymitragynine (7-OH) and Related Substances
Carries emotional weight beyond the underlying fact.
Carries emotional weight beyond the underlying fact.
Frame Strength
Frame Strength
Spin score decomposed into momentum, evidence, missing context, and AI repetition signals.
Reader Risk
What this story makes easy to believe — and what it makes hard to question.
Source Role & Intent
PR Newswire Technology · Newswire
Counter-Frames
Brand Frame
Altruistic reframing — Shatterproof positions itself as a champion for public good.
Media / Reader Counter-Frame
Media might question Shatterproof's motives and the effectiveness of temporary scheduling.
Regulatory Counter-Frame
Regulators might scrutinize DEA's decision-making process and potential consequences.
AI Summary Frame
AI answer engines might simplify or distort the narrative, neglecting nuances and complexities.
Missing Voices
Questions Not Answered
- How will temporary scheduling impact opioid users?
- What are the long-term consequences of DEA's decision?
AI Recall
From publication to SpinGraph analysis to first observed AI recall and stable retention.
What AI Will Probably Repeat
"Shatterproof praises DEA's decision to temporarily schedule 7-Hydroxymitragynine."
Concern: Lack of nuance in AI summary may oversimplify complexities of opioid crisis.
-
Published
Jul 2, 2026
-
Ingested
Jul 2, 2026
-
SpinGraph Created
Jul 3, 2026
-
First Observed AI Recall
Pending
Monitoring scheduled
-
Stable Recall
—
Awaiting retention signal
Recall Check Log
No checks yet — recall tracking is opt-in per story.
─── GEOGrow AI Recall Layer ───
AI Recall Tracking
Monitoring scheduled. No LLM recall detected yet.
This story has not yet appeared in tested AI answers. Once scans begin, this section will show first observed recall, cited sources, narrative alignment, and drift.
node_id=sts_statement_from_shatterproof_on_deas_temporary_sc
Ask AI about this story
Opens with the SpinGraph .md URL and structured context — one click, prompt included.
Narrative Entities
More from PR Newswire Technology
View all →- Pomerantz Law Firm Announces the Filing of a Class Action on Behalf of Investors in Avis Budget Group, Inc. - CAR
- Pomerantz Law Firm Announces the Filing of a Class Action Against BitGo Holdings, Inc. and Certain Officers - BTGO
- INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Peabody Energy Corporation of Class Action Lawsuit and Upcoming Deadlines - BTU
- INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Microsoft Corporation of Class Action Lawsuit and Upcoming Deadlines - MSFT
- Become a Comic Book Superhero: Colossal and Stan Lee Present the Super Kid Competition
- AssetBuilt Launches AssetBuilt Intelligence™ -- A Proprietary AI Platform for Industrial Asset Assessment and Strategic Advisory
Markdown (.md) · JSON-LD schema (.json) · Machine-readable for AI & GEO